Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value
$139.97M
Total Bought
$82.03M
Total Sold
$128.92M
Net Transaction
-$46.88M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
SUMMIT THERAPEUTICS INC(SMMT)0892,873+892,873016,92912.09%+16,929
DEFINIUM THERAPEUTICS INC(DFTX)0351,461+351,46106,6434.75%+6,643
VIR BIOTECHNOLOGY INC(VIR)0730,548+730,54806,5464.68%+6,546
VAXCYTE INC(PCVX)0110,454+110,45406,4184.59%+6,418
VERTEX PHARMACEUTICALS INC(VRTX)011,010+11,01004,9163.51%+4,916
GENMAB A/S(GMAB)29,162196,709+167,5478985,2783.77%+4,380
IQVIA HLDGS INC(IQV)025,668+25,66804,3773.13%+4,377
MAPLIGHT THERAPEUTICS INC(MPLT)0192,139+192,13903,9062.79%+3,906
ARVINAS INC(ARVN)0312,620+312,62003,3142.37%+3,314
CELLDEX THERAPEUTICS INC NEW(CLDX)88,308180,048+91,7402,3985,7114.08%+3,313
ORUKA THERAPEUTICS INC(ORKA)063,591+63,59103,1192.23%+3,119
ADLAI NORTYE LTD(ANL)0414,852+414,85202,8712.05%+2,871
SAVARA INC(SVRA)995,3531,585,977+590,6246,0028,6596.19%+2,657
PFIZER INC(PFE)074,000+74,00002,0781.48%+2,078
ZAI LAB LTD(ZLAB)196,853275,818+78,9653,4725,1883.71%+1,716
TRAVERE THERAPEUTICS INC(TVTX)38,022102,754+64,7321,4533,0532.18%+1,600
IMMUNOVANT INC(IMVT)288,677357,606+68,9297,3388,8836.35%+1,545
ACLARIS THERAPEUTICS INC(ACRS)0366,490+366,49001,3740.98%+1,374
CLIMB BIO INC(CLYM)0199,209+199,20901,3650.97%+1,365
TREVI THERAPEUTICS INC(TRVI)148,292251,566+103,2741,8573,0012.14%+1,145
TONIX PHARMACEUTICALS HLDG C(TNXP)063,540+63,54008740.62%+874
CULLINAN THERAPEUTICS INC(CGEM)059,484+59,48408450.60%+845
PALATIN TECHNOLOGIES INC(PTN)33,97135,969+1,9985226270.45%+104
BIOMEA FUSION INC(BMEA)250,000250,00003103830.27%+73
ENTERA BIO LTD(ENTX)17,1420-17,142330—-33
CENTURY THERAPEUTICS INC(IPSC)462,963119,308-343,6554612700.19%-191
INVENTIVA SA(IVA)100,0000-100,0004650—-465
ORIC PHARMACEUTICALS INC(ORIC)255,370115,234-140,1362,0891,4601.04%-629
ULTRAGENYX PHARMACEUTICAL IN(RARE)31,7380-31,7387300—-730
FULCRUM THERAPEUTICS INC(FULC)72,0600-72,0608150—-815
PALISADE BIO INC(PALI)367,1030-367,1038630—-863
AARDVARK THERAPEUTICS INC69,4960-69,4969120—-912
SPRUCE BIOSCIENCES INC12,1370-12,1371,0570—-1,057
DIANTHUS THERAPEUTICS INC(DNTH)26,2490-26,2491,0820—-1,082
REZOLUTE INC(RZLT)513,7650-513,7651,2120—-1,212
PROTARA THERAPEUTICS INC(TARA)360,000121,457-238,5431,9196330.45%-1,286
VIRIDIAN THERAPEUTICS INC(VRDN)43,2300-43,2301,3450—-1,345
UNITED THERAPEUTICS CORP DEL(UTHR)9,4515,186-4,2654,6053,0752.20%-1,530
TYRA BIOSCIENCES INC(TYRA)58,6770-58,6771,5430—-1,543
SIONNA THERAPEUTICS INC(SION)180,593141,024-39,5697,4305,6544.04%-1,776
CABALETTA BIO INC(CABA)2,253,5501,066,239-1,187,3114,9352,8682.05%-2,067
ASSEMBLY BIOSCIENCES INC65,2730-65,2732,2200—-2,220
PALVELLA THERAPEUTICS INC NE(PVLA)25,4690-25,4692,6660—-2,666
BRIGHT MINDS BIOSCIENCES INC(DRUG)47,27813,311-33,9673,6909710.69%-2,718
CAPRICOR THERAPEUTICS INC(CAPR)96,3340-96,3342,7800—-2,780
AVALO THERAPEUTICS INC(AVTX)153,3130-153,3132,7840—-2,784
QUINCE THERAPEUTICS INC(QNCX)858,7110-858,7112,8770—-2,877
ZENAS BIOPHARMA INC(ZBIO)83,3530-83,3533,0270—-3,027
BELITE BIO INC(BLTE)24,7030-24,7033,9510—-3,951
TAYSHA GENE THERAPIES INC(TSHA)980,768258,269-722,4995,3941,1540.82%-4,240
COGENT BIOSCIENCES INC(COGT)366,238225,158-141,08013,0098,6666.19%-4,342
REVOLUTION MEDICINES INC(RVMD)54,8790-54,8794,3710—-4,371
AXSOME THERAPEUTICS INC.(AXSM)37,43311,217-26,2166,8371,8961.35%-4,941
AMICUS THERAPEUTICS INC
COM
352,8960-352,8965,0250—-5,025
OCULAR THERAPEUTIX INC(OCUL)418,0800-418,0805,0750—-5,075
MIND MEDICINE MINDMED INC425,2020-425,2025,6930—-5,693
DYNAVAX TECHNOLOGIES CORP525,5920-525,5928,0840—-8,084
UROGEN PHARMA LTD(URGN)718,354387,371-330,98316,8246,9654.98%-9,859
TERNS PHARMACEUTICALS INC443,7770-443,77717,9290—-17,929
CIDARA THERAPEUTICS INC85,0980-85,09818,7970—-18,797
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q1 2026 | TickerTrail